Ignite Creation Date:
2024-05-06 @ 1:40 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01864772
Status:
COMPLETED
Last Update Posted:
2022-08-19
First Post:
2013-05-21
Brief Title:
Phase II Trial of Carboplatin 5-FU and Cetuximab in Elderly Fit no Frailty Patients With RecurrentMetastatic HNSCC
Sponsor:
Groupe Oncologie Radiotherapie Tete et Cou
Organization:
Groupe Oncologie Radiotherapie Tete et Cou
Organization Data
Organization:
Groupe Oncologie Radiotherapie Tete et Cou
Class:
OTHER
Study ID:
GORTEC ELAN-FIT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Groupe Oncologie Radiotherapie Tete et Cou
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Gustave Roussy Cancer Campus Grand Paris | OTHER |